Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracervical vs Intramyometrial Vasopressin in Abdominal Myomectomy
NCT02377492Withdrawn
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Mar 2015
- Primary completion
- Mar 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of vasopressin in Uterine Fibroids (UF) (2 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Estimated Blood Loss at 1 day. Planned start Mar 2015; status: withdrawn.
02
Drugs
vasopressin
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT02377492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02377492.